Next Generation Sequencing (NGS) provides comprehensive genomic information about disease, development, and other biological processes. Though the NGS workflow has been vastly simplified, there are ...
Data will be presented on new and upcoming technologies, including fast, streamlined library preparation, plus new technologies for epigenetics and new sequencing platforms. Specifically, NEB will ...
IPSWICH, Mass. and PARIS, June 18, 2024 /PRNewswire/ -- New England Biolabs (NEB ®) and Inorevia announce a collaboration to develop automated workflows to maximize data quality by preparation of ...
In today’s rapidly evolving landscape of next-generation sequencing (NGS), researchers face mounting pressure to deliver high-quality data from increasingly diverse and challenging sample types. From ...
Although next-generation sequencing (NGS) keeps giving—exploring the human genome and revolutionizing our knowledge of health and disease—it needs to take a little, too. At the very least, NGS ...
Whole genome analysis plays a critical role in the development of life-saving diagnostics, therapeutics, and vaccines, with growing interest in noncoding regions and Whole genome analysis plays a ...
Cell-free DNA (cfDNA) can act as a powerful biomarker for cancer research, from disease onset to therapy selection and minimal residual disease (MRD) measurement. Next-generation sequencing (NGS) has ...
IPSWICH, Mass., Feb. 21, 2025 /PRNewswire/ -- New England Biolabs (NEB ®) will be presenting a host of technologies aimed at streamlining sample preparation technologies towards the production of high ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback